Desktop Site |
03 Jul 24 | 11:18 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 79,919.20 +477.75 +0.60 %
Corporate Announcement
  • Security Code532321
    CompanyZydus Lifesciences Ltd
    Exchange Received Time28/06/2024 17:32:03
    Exchange Disseminated Time28/06/2024 17:32:03
    Time Taken00:00:00
     
     
     Announcement under Regulation 30 (LODR)-Press Release / Media Release | 6/28/2024 5:32:03 PM 
     Zydus and Dr. Reddy''s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(24) 03 Jul 24|11:18 (IST)